Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations.

× No keyword cloud information.

13 in total

1. Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors: J T Gilman; P Gal
Journal: Clin Pharmacokinet Date: 1992-07 Impact factor: 6.447

2. The Need for Pediatric Drug Development.

Authors: Robert M Ward; Daniel K Benjamin; Jonathan M Davis; Richard L Gorman; Ralph Kauffman; Gregory L Kearns; Mary Dianne Murphy; Catherine M T Sherwin
Journal: J Pediatr Date: 2017-09-21 Impact factor: 4.406

Review 3. Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities.

Authors: Jean C Dinh; Chelsea M Hosey-Cojocari; Bridgette L Jones
Journal: Paediatr Drugs Date: 2020-02 Impact factor: 3.022

Review 4. Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Authors: R E Kauffman; G L Kearns
Journal: Clin Pharmacokinet Date: 1992-07 Impact factor: 6.447

5. Neonatal theophylline intoxication: pharmacokinetics and clinical evaluation.

Authors: H Skopnik; U Bergt; G Heimann
Journal: Eur J Pediatr Date: 1992-03 Impact factor: 3.183

Review 6. Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors: J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal: Clin Pharmacokinet Date: 1994-04 Impact factor: 6.447

Review 7. Clinical pharmacokinetics in infants and children. A reappraisal.

Authors: G L Kearns; M D Reed
Journal: Clin Pharmacokinet Date: 1989 Impact factor: 6.447

8. Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?

Authors: Klaus Rose; Philip D Walson
Journal: Paediatr Drugs Date: 2017-12 Impact factor: 3.022

9. Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.

Authors: Amanda England; Kelly Wade; P Brian Smith; Katherine Berezny; Matthew Laughon
Journal: Contemp Clin Trials Date: 2016-03-09 Impact factor: 2.261

10. Pediatric Melanoma and Drug Development.

Authors: Klaus Rose; Jane M Grant-Kels
Journal: Children (Basel) Date: 2018-03-20